Adam Maeder

Stock Analyst at Piper Sandler

(0)
# 3832
Out of 5,218 analysts
123
Total ratings
55.38%
Success rate
-0.06%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Vicarious Surgical
Maintains: Neutral
12 11
14.2 -26.06% 6 Nov 13, 2024
Nevro
Maintains: Underweight
7 6
4.08 47.06% 15 Nov 12, 2024
Inspire Medical Syst...
Reiterates: Overweight
255 260
188.34 38.05% 13 Nov 5, 2024
Inari Medical
Maintains: Neutral
50 52
55.66 -6.58% 6 Oct 29, 2024
Edwards Lifesciences
Maintains: Neutral
73 70
73.33 -4.54% 12 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
495 538
539.38 -0.26% 17 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
131 133
113.45 17.23% 2 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
2.97 51.52% 3 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
16.52 27.12% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
n/a n/a 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
n/a n/a 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
1.12 614.29% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
7.99 150.31% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
25 30
17.95 67.13% 2 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.35 112.77% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
8.16 120.59% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
51.57 91.97% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
n/a n/a 5 Jun 14, 2021